Shandong Pharmaceutical GlassLtd Valuation
Is 600529 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
6/6Valuation Score 6/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 600529 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 600529 (CN¥24.5) is trading below our estimate of fair value (CN¥107.66)
Significantly Below Fair Value: 600529 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 600529?
Key metric: As 600529 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 600529's PE Ratio? | |
|---|---|
| PE Ratio | 18.4x |
| Earnings | CN¥882.00m |
| Market Cap | CN¥16.26b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.6x |
| Enterprise Value/EBITDA | 10x |
| PEG Ratio | 1x |
Price to Earnings Ratio vs Peers
How does 600529's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 22.9x | ||
300595 Autek China | 25.9x | 16.8% | CN¥16.9b |
301371 Harbin Fuerjia Technology | 20.3x | 8.4% | CN¥14.8b |
688029 Micro-Tech (Nanjing)Ltd | 24.6x | 19.0% | CN¥13.5b |
603658 Autobio Diagnostics | 20.9x | 20.9% | CN¥26.6b |
600529 Shandong Pharmaceutical GlassLtd | 18.4x | 18.4% | CN¥16.3b |
Price-To-Earnings vs Peers: 600529 is good value based on its Price-To-Earnings Ratio (18.4x) compared to the peer average (22.9x).
Price to Earnings Ratio vs Industry
How does 600529's PE Ratio compare vs other companies in the CN Medical Equipment Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: 600529 is good value based on its Price-To-Earnings Ratio (18.4x) compared to the CN Medical Equipment industry average (34.6x).
Price to Earnings Ratio vs Fair Ratio
What is 600529's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 18.4x |
| Fair PE Ratio | 24.5x |
Price-To-Earnings vs Fair Ratio: 600529 is good value based on its Price-To-Earnings Ratio (18.4x) compared to the estimated Fair Price-To-Earnings Ratio (24.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CN¥24.50 | CN¥31.53 +28.7% | 3.3% | CN¥33.00 | CN¥30.50 | n/a | 5 |
| Nov ’25 | CN¥25.00 | CN¥31.53 +26.1% | 3.3% | CN¥33.00 | CN¥30.50 | n/a | 5 |
| Oct ’25 | CN¥29.12 | CN¥32.36 +11.1% | 8.1% | CN¥37.20 | CN¥30.00 | n/a | 5 |
| Sep ’25 | CN¥24.50 | CN¥31.77 +29.7% | 5.9% | CN¥35.00 | CN¥30.50 | n/a | 4 |
| Aug ’25 | CN¥24.01 | CN¥35.20 +46.6% | 8.2% | CN¥38.01 | CN¥30.60 | n/a | 4 |
| Jul ’25 | CN¥25.66 | CN¥35.20 +37.2% | 8.2% | CN¥38.01 | CN¥30.60 | n/a | 4 |
| Jun ’25 | CN¥26.17 | CN¥35.20 +34.5% | 8.2% | CN¥38.01 | CN¥30.60 | n/a | 4 |
| May ’25 | CN¥28.18 | CN¥35.20 +24.9% | 8.2% | CN¥38.01 | CN¥30.60 | n/a | 4 |
| Apr ’25 | CN¥30.45 | CN¥34.47 +13.2% | 1.4% | CN¥35.00 | CN¥34.00 | n/a | 4 |
| Mar ’25 | CN¥26.27 | CN¥34.47 +31.2% | 1.4% | CN¥35.00 | CN¥34.00 | n/a | 4 |
| Feb ’25 | CN¥23.55 | CN¥34.47 +46.4% | 1.4% | CN¥35.00 | CN¥34.00 | n/a | 4 |
| Jan ’25 | CN¥25.60 | CN¥34.98 +36.6% | 3.1% | CN¥37.00 | CN¥34.00 | n/a | 5 |
| Dec ’24 | CN¥26.30 | CN¥36.18 +37.6% | 9.5% | CN¥43.00 | CN¥34.00 | n/a | 5 |
| Nov ’24 | CN¥27.74 | CN¥36.18 +30.4% | 9.5% | CN¥43.00 | CN¥34.00 | CN¥25.00 | 5 |
| Oct ’24 | CN¥27.85 | CN¥34.58 +24.2% | 8.5% | CN¥40.00 | CN¥32.00 | CN¥29.12 | 5 |
| Sep ’24 | CN¥26.59 | CN¥34.30 +29.0% | 8.9% | CN¥40.00 | CN¥32.00 | CN¥24.50 | 5 |
| Aug ’24 | CN¥26.03 | CN¥33.30 +27.9% | 5.6% | CN¥36.00 | CN¥31.00 | CN¥24.01 | 5 |
| Jul ’24 | CN¥27.22 | CN¥33.30 +22.3% | 5.6% | CN¥36.00 | CN¥31.00 | CN¥25.66 | 5 |
| Jun ’24 | CN¥25.51 | CN¥33.10 +29.7% | 6.4% | CN¥36.00 | CN¥30.00 | CN¥26.17 | 5 |
| May ’24 | CN¥24.58 | CN¥34.37 +39.8% | 3.6% | CN¥36.00 | CN¥32.60 | CN¥28.18 | 4 |
| Apr ’24 | CN¥26.25 | CN¥36.56 +39.3% | 6.0% | CN¥40.00 | CN¥34.00 | CN¥30.45 | 4 |
| Mar ’24 | CN¥29.11 | CN¥36.56 +25.6% | 6.0% | CN¥40.00 | CN¥34.00 | CN¥26.27 | 4 |
| Feb ’24 | CN¥29.37 | CN¥36.56 +24.5% | 6.0% | CN¥40.00 | CN¥34.00 | CN¥23.55 | 4 |
| Jan ’24 | CN¥28.40 | CN¥36.56 +28.7% | 6.0% | CN¥40.00 | CN¥34.00 | CN¥25.60 | 4 |
| Dec ’23 | CN¥29.50 | CN¥37.42 +26.8% | 4.9% | CN¥40.00 | CN¥35.80 | CN¥26.30 | 3 |
| Nov ’23 | CN¥29.14 | CN¥36.13 +24.0% | 0.9% | CN¥36.45 | CN¥35.80 | CN¥27.74 | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Winner Medical
CN¥20.4b
Engages in the research and development, manufacture, and marketing of cotton-based medical dressings and medical disposables, and consumer products in China.
300888
CN¥35.10
7D
-0.9%
1Y
-9.8%
Chison Medical Technologies
CN¥3.0b
Manufactures and sells diagnostic ultrasound systems in China and internationally.
688358
CN¥26.68
7D
2.9%
1Y
-39.1%
iRay Technology
CN¥16.2b
Develops, manufactures, and sells flat panel X-ray detectors for use in medical, dental, oncology, veterinary, security, and industrial imaging applications in China and internationally.
688301
CN¥113.80
7D
-2.7%
1Y
-27.9%